MedPath

Feasibility study of a short Trastuzumab infusion in patients with breast cancer.

Not Applicable
Conditions
breast cancer
Registration Number
JPRN-UMIN000018294
Lead Sponsor
IPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1)Systemic administration of corticosteroids 2)At the same time, used other molecular target drugs 3)Patients whose participation in the trial is judged to be inappropriate by the attending doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Having onset of hypersensitivity reaction or not
Secondary Outcome Measures
NameTimeMethod
grade of infusion related reaction(CTCAE v.4.0),feasibility,causality of between hypersensitivity and BMI and stage
© Copyright 2025. All Rights Reserved by MedPath